Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Behavioral and Social Science

Abstract A39: GMaP Region 4 clinical trials outreach for Latinos

Rose A. Treviño-Whitaker, Amelie G. Ramirez, Kipling Gallion and Mary O'Connell
Rose A. Treviño-Whitaker
1University of Texas Health Science Center at San Antonio, San Antonio, TX,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amelie G. Ramirez
1University of Texas Health Science Center at San Antonio, San Antonio, TX,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kipling Gallion
1University of Texas Health Science Center at San Antonio, San Antonio, TX,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mary O'Connell
2New Mexico State University, Las Cruces, NM.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1538-7755.DISP14-A39 Published October 2015
  • Article
  • Info & Metrics
Loading
Abstracts: Seventh AACR Conference on The Science of Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; November 9-12, 2014; San Antonio, TX

Abstract

Background: One of the National Cancer Institute's (NCI) Center to Reduce Cancer Health Disparities (CRCHD) Transdisciplinary Geographical Management of Cancer Health Disparities Program (GMAP) focuses is to connect underrepresented communities with research, training and outreach efforts. GMaP Region 4 composed of 9 states (Arizona, Colorado, Kansas, Nebraska, New Mexico, Oklahoma, Texas Utah and Wyoming), developed Clinical Trials Outreach for Latinos (CTOL) and educational module to help close the gap of clinical trial and biospecimen information within our minority community. Although clinical trials are operational in some of our sites, the overall number of eligible clinical trial participants per site is much higher than the number of actual participants in clinical trials. Drawing on the Region 4 Implementation Plan, which identified the need for CT accrual especially among low income English- and Spanish-speaking Latinos, we developed an intervention to test a CT education and outreach project in at least five different sites in Region 4.

CTOL Program Purpose:

  • Increase Latinos' informed decision-making about joining clinical trials and donating biospecimens.

  • Highlight the importance of participating in trials and donating biospecimens.

  • Discuss risks and benefits of participation in trials and donating biospecimens.

  • Provide resources for available local and national trials and biobanks.

Methodology: The CTOL involved the design and testing of a pilot CT education program through focus groups to implementation of the module. The project coordinator/health educator identified community organizations to the introduce CTOL and arranged for the educational sessions. The outreach strategy was to conduct a 20 to 30 minute session “piggy backed” into regularly scheduled group meetings. Prior to the presentation participants were asked to provide demographic information in a sign-in sheet. The presentations contained 4 pre-evaluation questions in which participants were asked to raise their hand if they agreed with the statement. After the session, participants asked questions and then answered several post-evaluation questions.

Results: Seventy-two education sessions were conducted at five sites: 1) The University of Texas Health Science Center San Antonio, 2) New Mexico State University, 3) University of Arizona Cancer Center, 4) Good Samaritan Hospital (NE), and 5) Penrose Cancer Center (CO). The GMaP program in Region 4 included over 1200 participants in 12 different cities in 5 states (AZ, CO, NE, NM, and TX). Participants represented 155 different zip codes with the majority being Hispanic white females. At the beginning of the sessions, about 60% had heard about clinical trials however not many people really understood how they worked (33%) and fewer people neither understood nor knew about biospecimens or biobanks (17%). At the end of the sessions most participants gained knowledge about clinical trials and biospecimens with most post questions receiving over 80% “yes” responses. Sixty percent indicated they would be interested in future participation in clinical trials and biospecimen collection.

Conclusions: Tailoring the form, content and delivery of education materials to an intended audience are essential for an effective program or intervention. We found that participants were not very informed about clinical trials or biospecimens but indicated that their knowledge and attitudes towards these issues increased or improved after exposure to our CTOL. Based on our findings we continued to refine the program and created “The Clinical Trials Outreach for Latinos: Program Replication Manual”, which we believe could assist other communities and stakeholders to disseminate this information and program in their own communities.

Citation Format: Rose A. Treviño-Whitaker, Amelie G. Ramirez, Kipling Gallion, Mary O'Connell. GMaP Region 4 clinical trials outreach for Latinos. [abstract]. In: Proceedings of the Seventh AACR Conference on The Science of Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; Nov 9-12, 2014; San Antonio, TX. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2015;24(10 Suppl):Abstract nr A39.

  • ©2015 American Association for Cancer Research.
Previous
Back to top
Cancer Epidemiology Biomarkers & Prevention: 24 (10 Supplement)
October 2015
Volume 24, Issue 10 Supplement
  • Table of Contents

Sign up for alerts

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Epidemiology, Biomarkers & Prevention article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Abstract A39: GMaP Region 4 clinical trials outreach for Latinos
(Your Name) has forwarded a page to you from Cancer Epidemiology, Biomarkers & Prevention
(Your Name) thought you would be interested in this article in Cancer Epidemiology, Biomarkers & Prevention.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Abstract A39: GMaP Region 4 clinical trials outreach for Latinos
Rose A. Treviño-Whitaker, Amelie G. Ramirez, Kipling Gallion and Mary O'Connell
Cancer Epidemiol Biomarkers Prev October 1 2015 (24) (10 Supplement) A39; DOI: 10.1158/1538-7755.DISP14-A39

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Abstract A39: GMaP Region 4 clinical trials outreach for Latinos
Rose A. Treviño-Whitaker, Amelie G. Ramirez, Kipling Gallion and Mary O'Connell
Cancer Epidemiol Biomarkers Prev October 1 2015 (24) (10 Supplement) A39; DOI: 10.1158/1538-7755.DISP14-A39
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

Behavioral and Social Science

  • Abstract C09: Building capacity to conduct cancer disparities research: Progress and evaluation of NCI CRCHD P20 GUIDE Project
  • Abstract B08: Acceptability of text messaging for communication of health information among Black and low-income women following abnormal cervical cancer screening
  • Abstract C34: [Advocate Abstract:] Does culture play a role in cancer survivorship?
Show more Behavioral and Social Science

Health Education

  • Abstract C09: Building capacity to conduct cancer disparities research: Progress and evaluation of NCI CRCHD P20 GUIDE Project
  • Abstract C06: Adapting a breast cancer education program to reach Arab Muslim women
  • Abstract C13: Knowledge and perceptions on colorectal cancer among male adults taking herbal remedies against anorectal or gastrointestinal disorders in rural Zaria, Nigeria
Show more Health Education

Health Education: Poster Presentations - Proffered Abstracts

  • Abstract C09: Building capacity to conduct cancer disparities research: Progress and evaluation of NCI CRCHD P20 GUIDE Project
  • Abstract C06: Adapting a breast cancer education program to reach Arab Muslim women
  • Abstract C13: Knowledge and perceptions on colorectal cancer among male adults taking herbal remedies against anorectal or gastrointestinal disorders in rural Zaria, Nigeria
Show more Health Education: Poster Presentations - Proffered Abstracts
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Epidemiology, Biomarkers & Prevention

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Epidemiology, Biomarkers & Prevention
eISSN: 1538-7755
ISSN: 1055-9965

Advertisement